Thus, promotion of continuous proliferation and self-renewal of CD62LintCD44high cells in secondary lymphoid tissues could help supply CD62L+Bcl6+ cells within the tumor, augmenting anti-tumor immunity. This evidence concerns the gene SELL and neoplasm.